Thyrocare Technologies Ltd: Stock Analysis & Fundamentals

Updated this week

Thyrocare Technologies Ltd (Diagnostics) — fundamental analysis, earnings data, and key metrics. PE: 40.5. ROE: 16.2%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

🌐FII stake increased 2.9% this quarter

🏛️DII reducing — stake down 1.3%

Key Numbers

Current Price

₹361

Dividend Yield

1.94%

Market Cap

5.8K Cr

Valuation

N/A

← Back to Diagnostics Dashboard

Frequently Asked Questions: Thyrocare Technologies Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Thyrocare Technologies Ltd's latest quarterly results?

Thyrocare Technologies Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: +47.4%
Revenue Growth YoY: +18.1%
Operating Margin: 30.0%

What is Thyrocare Technologies Ltd's current PE ratio?

Thyrocare Technologies Ltd's current PE ratio is 40.5x.

Current PE: 40.5x
Market Cap: 5.8K Cr
Dividend Yield: 1.94%

What is Thyrocare Technologies Ltd's price-to-book ratio?

Thyrocare Technologies Ltd's price-to-book ratio is 10.7x.

Price-to-Book (P/B): 10.7x
Book Value per Share: ₹34
Current Price: ₹361

Is Thyrocare Technologies Ltd a fundamentally strong company?

Thyrocare Technologies Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 25.0%

Is Thyrocare Technologies Ltd debt free?

Thyrocare Technologies Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹25 Cr

What is Thyrocare Technologies Ltd's return on equity (ROE) and ROCE?

Thyrocare Technologies Ltd's return ratios over recent years

FY2023: ROCE 17.0%
FY2024: ROCE 18.0%
FY2025: ROCE 25.0%

Is Thyrocare Technologies Ltd's cash flow positive?

Thyrocare Technologies Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹191 Cr
Free Cash Flow (FCF): ₹138 Cr
CFO/PAT Ratio: 210% (strong cash conversion)

What is Thyrocare Technologies Ltd's dividend yield?

Thyrocare Technologies Ltd's current dividend yield is 1.94%.

Dividend Yield: 1.94%
Current Price: ₹361

Who holds Thyrocare Technologies Ltd shares — promoters, FII, DII?

Thyrocare Technologies Ltd's shareholding pattern (Dec 2025)

Promoters: 60.9%
FII (Foreign): 5.0%
DII (Domestic): 20.5%
Public: 13.6%

Is promoter holding increasing or decreasing in Thyrocare Technologies Ltd?

Thyrocare Technologies Ltd's promoter holding has decreased recently.

Current Promoter Holding: 60.9% (Dec 2025)
Previous Quarter: 71.1% (Sep 2025)
Change: -10.13% (decreasing — worth monitoring)

Is Thyrocare Technologies Ltd a new momentum entry or an established outperformer?

Thyrocare Technologies Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Thyrocare Technologies Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Thyrocare Technologies Ltd may be worth studying

Cash flow is positive — CFO ₹191 Cr

What is the investment thesis for Thyrocare Technologies Ltd?

Thyrocare Technologies Ltd investment thesis summary:

What is the future outlook for Thyrocare Technologies Ltd?

Thyrocare Technologies Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.